FarhanaLatifMD

Heart Failure & Transplantation

Assistant Professor, Medicine, Columbia University College of Phys & Surg

Overview of Dr. Latif

Dr. Farhana Latif is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Albany Medical College and has been in practice 19 years. She is one of 697 doctors at New York-Presbyterian Hospital and one of 322 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Cardiology. She has more than 70 publications and over 500 citings.

Office
622 W 168th St
Ph-3 Stem 137
New York, NY 10032
Book by Phone+1(929) 334-3436

Fax+1 212-342-3414

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)Fellowship, Cardiovascular Disease, 2002 - 2007
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1998 - 2001
Albany Medical CollegeClass of 1998

Certifications & Licensure

FL State Medical License 2022 - Present
NY State Medical License 2001 - 2025
NJ State Medical License 2008 - 2009
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Publications & Presentations

PubMed

12 citations
Peripheral blood mononuclear cell transcriptome profiles suggest T-cell immunosuppression after uncomplicated mechanical circulatory support device surgery.
Anshu Sinha, Khurram Shahzad, Farhana Latif, Martin Cadeiras, Manuel Prinz von Bayern
Human Immunology. 2010-02-01
29 citations
Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: A meta-analysis.
Douglas L. Jennings, Nicholas W. Lange, M. Shullo, Farhana Latif, Susan Restaino
International Journal of Cardiology. 2018-08-15
397 citations
(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
Sabahat Bokhari, Adam Castano, Ted Pozniakoff, Susan Deslisle, Farhana Latif
Circulation. Cardiovascular Imaging. 2013-03-01

Journal Articles

Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019
Farhana Latif, Maryjane A Farr, Kevin J Clerkin, Koji Takeda, Yoshifumi Naka, Susan Restaino, Gabriel Sayer, Nir Uriel, JAMA Cardiology

Authored Content

Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
Join now to see all